MedTrace Logo

Bisacodyl Use in the Post-operative Care of Obstetrical/Gynecological (OB/GYN) Patients

NCT01011426 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 285

Last updated 2014-01-20

No results posted yet for this study

Summary

The purpose of this study is to determine whether Bisacodyl, 5 mg usage decreases the incidence of nausea and abdominal pain after surgery, and also decreases the number of hospitalization days.

Conditions

Interventions

DRUG

Bisacodyl

5mg po 6 hours postoperatively, repeat in 12 hours if no flatus

DRUG

placebo

1 capsule po 6 hours after surgery; repeat in 12 hours if no flatus

Sponsors & Collaborators

  • The Cooper Health System

    lead OTHER

Principal Investigators

  • Meena Khandelwal, MD · Cooper University Hospital, NJ

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01011426 on ClinicalTrials.gov